ADI‑PEG20 (ADZODI®)
Malignant Pleural Mesothelioma and other arginine‑auxotrophic cancers
Commercial (licensed)Active
Key Facts
Indication
Malignant Pleural Mesothelioma and other arginine‑auxotrophic cancers
Phase
Commercial (licensed)
Status
Active
Company
About Tabuk Pharmaceuticals
Leading MENA generic drug maker expanding into specialty oncology through strategic partnerships.
View full company profile